Literature DB >> 11115092

Urea and nitrogen excretion in pediatric peritoneal dialysis patients.

S R Mendley1, N L Majkowski.   

Abstract

BACKGROUND: Adequate nutrition is critical to the care of children with end-stage renal disease, and failure to reach the target dietary intake is associated with growth failure. Prospective studies of urea and nitrogen output in adults have led to the derivation of quantitative relationships, which allow assessment of dietary protein intake when only urea appearance is known. Such a clinically useful relationship has not been defined in children receiving chronic peritoneal dialysis (PD).
METHODS: We studied 18 pediatric PD patients (ages 0.8 to 14.3 years) on 132 occasions and determined norms of urea nitrogen appearance (UNA), total nitrogen appearance (TNA), and nonurea nitrogen appearance (NUNA). We stratified data on UNA, TNA, NUNA, nonprotein nitrogen appearance, and the protein equivalent of nitrogen appearance by age groups (0 to 5, 6 to 10, and 11 to 15 years of age) and demonstrated significant differences. In addition, dietary protein and energy intake were measured in the outpatient setting with food scales and dietitian interviews, and the results were stratified by age, presence of residual renal function, and recombinant human growth hormone (rhGH) therapy.
RESULTS: UNA (3.05 +/- 1.38 g/day, 103 +/- 42 mg/kg/day) and TNA (4.67 +/- 1.86 g/day, 159 +/- 52 mg/kg/day) varied significantly between different age groups. NUNA in pediatric subjects (56 +/- 24 mg/kg/day) was significantly greater than previously published adult norms. A linear relationship was defined between UNA and TNA that was specific to pediatric PD patients [TNA (g/day) = 1.26(UNA) + 0.83]. When the relationship was scaled to body mass, the y intercept was significantly different in the youngest subjects [TNA = 1.03 (UNA) + 0.02 (weight in kg) + 0.56 (for subjects age 0 to 5) or 0.98 (for subjects age 11 to 15 or 6 to 10), r2 = 0.91]. Dietary protein intake was significantly greater in subjects receiving rhGH therapy, although nitrogen excretion was unchanged.
CONCLUSIONS: Markers of protein metabolism in pediatric PD patients are age dependent and differ from adult values. An age-specific relationship between TNA and UNA is defined for pediatric subjects; it does not vary with rhGH or the presence of residual renal function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11115092     DOI: 10.1046/j.1523-1755.2000.00442.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

Review 1.  Assessment of nutritional status in children with chronic kidney disease and on dialysis.

Authors:  Antonio Mastrangelo; Fabio Paglialonga; Alberto Edefonti
Journal:  Pediatr Nephrol       Date:  2013-09-05       Impact factor: 3.714

Review 2.  Strategies for the preservation of residual renal function in pediatric dialysis patients.

Authors:  Melissa A Cadnapaphornchai; Isaac Teitelbaum
Journal:  Pediatr Nephrol       Date:  2013-07-19       Impact factor: 3.714

3.  Malnutrition and its association with inflammation and vascular disease in children on maintenance dialysis.

Authors:  Nur Canpolat; Salim Caliskan; Lale Sever; Mehmet Tasdemir; Ozlem Balcı Ekmekci; Gulseren Pehlivan; Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2013-06-14       Impact factor: 3.714

4.  Nutrition assessment and management in children on peritoneal dialysis.

Authors:  Fabio Paglialonga; Alberto Edefonti
Journal:  Pediatr Nephrol       Date:  2008-02-06       Impact factor: 3.714

Review 5.  Residual renal function in children treated with chronic peritoneal dialysis.

Authors:  Maria Roszkowska-Blaim; Piotr Skrzypczyk
Journal:  ScientificWorldJournal       Date:  2013-11-24

6.  Taurine: A Potential Ergogenic Aid for Preventing Muscle Damage and Protein Catabolism and Decreasing Oxidative Stress Produced by Endurance Exercise.

Authors:  Flávia G De Carvalho; Bryan S M Galan; Priscila C Santos; Kelly Pritchett; Karina Pfrimer; Eduardo Ferriolli; Marcelo Papoti; Júlio S Marchini; Ellen C de Freitas
Journal:  Front Physiol       Date:  2017-09-20       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.